Sentences Generator
And
Your saved sentences

No sentences have been saved yet

"nocebo" Definitions
  1. a harmless substance or treatment that when taken by or administered to a patient is associated with harmful side effects or worsening of symptoms due to negative expectations or the psychological condition of the patient

117 Sentences With "nocebo"

How to use nocebo in a sentence? Find typical usage patterns (collocations)/phrases/context for "nocebo" and check conjugation/comparative form for "nocebo". Mastering all the usages of "nocebo" from sentence examples published by news publications.

" EHS is understood as a product of the "nocebo effect.
But the placebo effect has an evil twin: the nocebo.
The researchers here wondered if the same applied to nocebo.
Evidence suggests that the muscle aches might be a big nocebo.
Like the placebo effect, the nocebo effect is influenced by expectations.
"People respond to nocebo even with verbal suggestions," she told me.
As Mr. A showed us, the nocebo effect can be surprisingly powerful.
When Benedetti gave people a CCK blocker, it stopped nocebo-effect pain.
But calling something placebo or nocebo doesn't mean it's not real or physical.
Nocebo effects are associated with changes in several brain areas, neurotransmitters and hormones.
The nocebo effect, from the Latin for "I will harm," works the opposite way.
This phenomenon is known as the "nocebo effect," the opposite of the placebo effect.
One person had a nocebo effect—taking the inactive capsule brought on negative feelings.
This phenomenon is known as the nocebo effect, the opposite of the placebo effect.
Some researchers suspect the nocebo effect is partly fueling the gluten-free diet fad.
Nocebo is "placebo's evil twin," says Irving Kirsch, a faculty member at Harvard Medical School.
The psychology of myalgias involves the nocebo effect, the flip side of the placebo effect.
There is such thing as the nocebo effect: where negative expectations make people feel worse.
These are all important components of how the placebo or nocebo effect will play out.
One of the reasons health professionals insist on further investigation is something called a nocebo effect.
The influence of negative expectation—of fear—on our health is known as the nocebo effect .
When I told contemporary nocebo researchers about Barker's work, they sensed a lure in the trap.
The nocebo effect is the opposite: Patients can experience adverse effects solely because they anticipate them.
But scientists are also learning there are ways to minimize or maximize the nocebo effect too.
So scientists are trying to understand more about the nocebo effect, to figure out how to avoid it.
"So much of conventional medicine actually could be legitimately criticized as exercises in the nocebo effect," Brown says.
But it's still hard to know the best way to harness the placebo effect and downplay the nocebo effect.
Researchers are still trying to figure all this out, and the nocebo effect is just starting to get research attention.
This Science study shows the healing power of the placebo isn't limitless — because where placebo lurks, nocebo may lurk too.
I'm an anxious person, and if I'm always ready to ignite my anxiety, it could lead to more nocebo effects.
These findings — and others about the nocebo effect — are key to design better clinical trials, as well as improve treatment outcomes.
Kirsch says that, maybe, informing patients about the nocebo effect, so they're aware of the power of expectations, could also help.
Nocebo is something of an inverse to this idea, instead of a creation of a space, it fixates on the absence.
The nocebo effect is sometimes referred to as placebo's evil twin; it translates to I shall cause harm or be harmful.
Their music is weightless and otherworldly, but the beautiful thing about their debut full-length Nocebo is that it's totally crushing too.
The nocebo effect Why don't people automatically believe it when a lot of women report the same side effect from a medication?
When a doctor tells someone she's going to experience a side effect, it can trigger a nocebo effect with real biological consequences.
The rest have other food sensitivities or a nocebo response to gluten, meaning they experience symptoms even when they're not actually eating gluten.
"It's the 'nocebo effect' at work—since there is no known science behind this," says Kamal Patel, nutritional researcher and director of Examine.
Whereas a placebo is an inert substance that exerts a beneficial effect, a nocebo is an inert substance that exerts an unpleasant effect.
Other studies have shown that nocebo effects engage a brain region called the hippocampus, but there's little evidence that the placebo effect does.
What researchers have realized in the past two decades is that the placebo and nocebo effects don't just change how we talk about symptoms.
The research isn't conclusive, but it hints that there may be some personality traits that are more likely to respond to placebo or nocebo.
As much as I dislike that fact, Colloca wrote in a 2017 Science magazine article that evolutionarily speaking, nocebo is around for a reason.
The nocebo effect is the phenomenon where a diagnosis, pill, or treatment provokes negative symptoms associated with that diagnosis, pill, or treatment in the patient.
If the placebo and nocebo effect are opposite sides of the same coin, how could I be so vulnerable to one and not the other?
Having a direct line to the nocebo effect, like I do, doesn't grant me access to the placebo effect too, like I thought it would.
It's mostly just convenient to talk about placebo and nocebo as opposites, she said, and their biological differences might explain why they have different triggers.
Throw that in a pot with some anxiety and OCD, and it's no wonder it feels like I'm a prime candidate for the nocebo effect.
" Nocebo is the second part of a trilogy of records that began with 2017's Isthmus, each of which, they say, explore the idea of "location.
Research has shown that placebo and nocebo effects can also be triggered by interactions with a doctor, even if your doctor tries to empathise with you.
Nocebo suggestions might work a little differently, Fabrizio Benedetti, a professor of physiology and neuroscience at the University of Turin Medical School in Italy, told me.
This means there were real biological changes taking place that led to the placebo and nocebo effects, and they could be interfered with by another drug.
About 5 percent developed myalgias while taking the statin atorvastatin (brand name Lipitor), and about half that many developed myalgias while taking placebo, or more precisely, nocebo.
Andersson thinks this could be associated with nocebo-like expectations, but he also says that to him, expectations producing symptoms doesn't mean that an illness is imagined.
"The mechanism underlying nocebo tends to show different characteristics," said Luana Colloca, a physician-scientist and an associate professor at the University of Maryland School of Nursing.
"If you're walking around being stressed around your food and being constantly worried, that is becoming kind of a self-fulfilling prophecy from the nocebo effect," he says.
If I want camaraderie, I can look to the many documented instances of mass psychogenic illnesses, when whole groups of people become sick because of the nocebo effect.
More research is the only way to find out whether what's being reported is a real side effect that has not been discovered before or just a nocebo effect.
In one of my favorite apocryphal anecdotes about the nocebo effect, as recounted in 1997, a hex was put on an 18-year-old Maori man in New Zealand.
For a person like me, if I was known to have a strong nocebo response, it might change the way my doctor told me test results or administered medication.
Most recently, in Cuba, it's thought that the diplomats who developed puzzling symptoms of memory loss, headaches, and hearing loss may have actually been victims of the nocebo effect.
The experimenters wondered: Could they manipulate the power of the nocebo effect, and make participants feel more or less pain after using the cream by priming them with an expectation?
"It suggests that, while nocebo responses are created in a faster and more immediate way, for placebo we need to consolidate an experience before we can show a bene t," she says.
Experts say the symptoms that are reported, like nausea and dizziness, may be real, but could stem from an expectation of harm, commonly known as the "nocebo" effect — the placebo effect's evil twin.
In more contemporary terms, she and other Swedish doctors create the conditions for a nocebo effect: the families expect that unless they are granted residency—the only medicine—their children will waste away.
It is important to know who is a placebo and nocebo responder so that we can better design trials for drugs, and so that doctors know the best way to interact with patients.
Moreover, the failure of the Mach 29 racing suit worn by the American team in 2014 could well have been due to the negative aspect of placebos, which is known as the nocebo effect.
The hippocampus is related to anxiety, which is at play in nocebo but generally not placebo, Ted Kaptchuk, the director of the Program in Placebo Studies at Beth Israel Deaconess Medical Center, told me.
Claeson and Andersson say this shows that the body is very good at predicting and defending itself from what it thinks will be damaging, which should make researchers cautious when interpreting nocebo and placebo results.
Now, in a new study published Thursday, the flip side of that coin — called the nocebo effect — has been seen in people who reported worse side effects when given what they thought was a higher priced medicine.
Keith Petrie, a professor of health psychology at the University of Auckland, has studied how nocebo effects can stem from the idea that the environment, medicine, architecture and technological advances in food are causes of poor health.
That's because those were the potential side effects they had been told about in the trial, which tells us something important: It's not the pill itself in the placebo or the nocebo effect that carries the magic.
With the media widely reporting just how dangerous fentanyl and other synthetic opioids are, maybe some cops have convinced themselves that the drug really can cause an overdose if you touch it, so they panic — essentially, a nocebo effect.
The placebo effect will never be a cure-all, but Colloca said she looks forward to a day when doctors don't just unwittingly nocebo their patients by rattling off potential side effects, but actively try to harness the placebo effect, too.
But the opioid blocker didn't reverse the effects of the CCK blocker and the CCK blocker didn't work for placebo, showing that the placebo and nocebo probably operate in slightly different ways—meaning these effects aren't exactly like twins, more like cousins.
" Nocebo for me has been finding the audacity to explore all the things I took away with me during the time I had one of my brothers in coma after his accident and the other in a comatose state after his cancer medications," she says.
Doctors and toxicologists who have studied the issue say that most of the cases reported so far are best explained by the so-called nocebo effect, a phenomenon whereby people who believe they have encountered a toxic substance experience the expected symptoms of that exposure.
Why this matters: "Understanding how nocebo effects work means that health care providers could actively use this knowledge in their way of talking to patients, how they explain things to patients and also which information to mention and to avoid in order to minimize the effect," one of the study authors, Alexandra Tinnermann, told Axios.
The worsening of the subject's symptoms or reduction of beneficial effects is a direct consequence of their exposure to the placebo, but those symptoms have not been chemically generated by the placebo. Because this generation of symptoms entails a complex of "subject-internal" activities, in the strictest sense, we can never speak in terms of simulator-centered "nocebo effects", but only in terms of subject-centered "nocebo responses". Although some observers attribute nocebo responses (or placebo responses) to a subject's gullibility, there is no evidence that an individual who manifests a nocebo/placebo response to one treatment will manifest a nocebo/placebo response to any other treatment; i.e., there is no fixed nocebo/placebo-responding trait or propensity.
Verbal suggestion can cause hyperalgesia (increased sensitivity to pain) and allodynia (perception of a tactile stimulus as painful) as a result of the nocebo effect. Nocebo hyperalgesia is believed to involve the activation of cholecystokinin receptors.
One article that reviewed 31 studies on nocebo effects reported a wide range of symptoms that could manifest as nocebo effects including nausea, stomach pains, itching, bloating, depression, sleep problems, loss of appetite, sexual dysfunction and severe hypotension.
Evidence suggests that the symptoms of electromagnetic hypersensitivity are caused by the nocebo effect.
A phenomenon opposite to the placebo effect has also been observed. When an inactive substance or treatment is administered to a recipient who has an expectation of it having a negative impact, this intervention is known as a nocebo (Latin nocebo = "I shall harm"). A nocebo effect occurs when the recipient of an inert substance reports a negative effect or a worsening of symptoms, with the outcome resulting not from the substance itself, but from negative expectations about the treatment. Another negative consequence is that placebos can cause side-effects associated with real treatment.
They also concluded that the studies supported the role of the nocebo effect in triggering acute symptoms in those with EHS.
In 1961 Walter Kennedy introduced the word nocebo to refer to a neutral substance that creates harmful effects in a patient who takes it.Kennedy, W. P., "The Nocebo Reaction", Medical World, Vol.95, (September 1961), pp. 203–5. In 1961 Henry K. Beecher concluded that surgeons he categorized as enthusiasts relieved their patients' chest pain and heart problems more than skeptic surgeons.
Stewart-Williams and Podd argue that using the contrasting terms "placebo" and "nocebo" to label inert agents that produce pleasant, health-improving, or desirable outcomes versus unpleasant, health-diminishing, or undesirable outcomes (respectively), is extremely counterproductive. For example, precisely the same inert agents can produce analgesia and hyperalgesia, the first of which, from this definition, would be a placebo, and the second a nocebo. A second problem is that the same effect, such as immunosuppression, may be desirable for a subject with an autoimmune disorder, but be undesirable for most other subjects. Thus, in the first case, the effect would be a placebo, and in the second, a nocebo.
A nocebo effect is said to occur when negative expectations of the patient regarding a treatment cause the treatment to have a more negative effect than it otherwise would have. For example, when a patient anticipates a side effect of a medication, they can suffer that effect even if the "medication" is actually an inert substance. The complementary concept, the placebo effect, is said to occur when positive expectations improve an outcome. Both placebo and nocebo effects are presumably psychogenic, but they can induce measurable changes in the body.
Symptoms may also be brought on by imagining that exposure is causing harm, an example of the nocebo effect. Studies have shown that reports of symptoms are more closely associated with belief that one is being exposed than with any actual exposure.
The thoughts, words and actions held in mind affect someone's intentions which makes the expected result happen. Although there are some cases where positive or negative attitudes can produce corresponding results (principally the placebo and nocebo effects), there is no scientific basis to the law of attraction.
It has been shown that, due to the nocebo effect, warning patients about side effects of drugs can contribute to the causation of such effects, whether the drug is real or not. This effect has been observed in clinical trials: according to a 2013 review, the dropout rate among placebo-treated patients in a meta-analysis of 41 clinical trials of Parkinson's disease treatments was 8.8%. A 2013 review found that nearly 1 out of 20 patients receiving a placebo in clinical trials for depression dropped out due to adverse events, which were believed to have been caused by the nocebo effect. A 2018 review found that half of patients taking placebos in clinical trials report intervention-related adverse events.
Failure to minimise nocebo side-effects in clinical trials and clinical practice raises a number of recently explored ethical issues. Withdrawal symptoms can also occur after placebo treatment. This was found, for example, after the discontinuation of the Women's Health Initiative study of hormone replacement therapy for menopause. Women had been on placebo for an average of 5.7 years.
Nocebo topped the Finnish album chart and was certified gold on the day of its release. Their sixth album, SLK, was released in February 2014. Stam1na made a historical series of performances in summer 2015 by playing the Provinssirock festival on four consecutive days, playing a different album from their discography in its entirety on each day. Their seventh studio album Elokuutio was released on 16 March 2016.
A placebo is a treatment with no intended therapeutic value. An example of a placebo is an inert pill, but it can include more dramatic interventions like sham surgery. The placebo effect is the concept that patients will perceive an improvement after being treated with an inert treatment. The opposite of the placebo effect is the nocebo effect, when patients who expect a treatment to be harmful will perceive harmful effects after taking it.
All of these are reasons why alternative therapies may be credited for improving a patient's condition even though the objective effect is non- existent, or even harmful. David Gorski argues that alternative treatments should be treated as a placebo, rather than as medicine. Almost none have performed significantly better than a placebo in clinical trials. Furthermore, distrust of conventional medicine may lead to patients experiencing the nocebo effect when taking effective medication.
Blumentopf booked him as support for their tour. Wasser has released most of his music free of charge, collaborating with other members of the German rap scene, most notably Cap Kendricks. In 2013 he joined Cap Kendricks, X, Phil Harmony, Paul and DJ Mic-e to form the band Dopeboy. After releasing the third installment of his Edgar Wasser Freetrack Collection, in 2013 he published the album Nocebo with of Creme Fresh.
Therapeutic effect refers to the response(s) after a treatment of any kind, the results of which are judged to be useful or favorable. This is true whether the result was expected, unexpected, or even an unintended consequence. An adverse effect (including nocebo) is the converse and refers to harmful or undesired response(s). What constitutes a therapeutic effect versus a side effect is a matter of both the nature of the situation and the goals of treatment.
McGlashan, Evans & Orne (1969, p. 319) found no evidence of what they termed a "placebo personality". Also, in a carefully designed study, Lasagna, Mosteller, von Felsinger and Beecher (1954), found that there was no way that any observer could determine, by testing or by interview, which subject would manifest a placebo reaction and which would not. Experiments have shown that no relationship exists between an individual's measured hypnotic susceptibility and their manifestation of nocebo or placebo responses.
As a coordinating scientist of systematic reviews in the CDC's Guide to Community Preventive Services, Hahn has published reviews on subjects such as excessive alcohol consumption and violence prevention, as well as interventions to promote health equity. He has also done research on the nocebo effect, and has said that one reason the medical community has been hesitant to research it because belief is not very highly valued in the modern medical community, which tends to focus more on anatomy.
They were also able to buy alcohol and over the next decade the twins became alcoholics - only Dasha drank, Masha was unable to because of a gag reflex. Because they shared the same blood supply, both would become inebriated. They made many attempts to stop drinking, which included hypnotism, magic spells and being 'sewn up', a process whereby a capsule (containing a nocebo chemical which would supposedly kill them upon inebriation) was inserted surgically under their skin. The pair visited Cologne, Germany, in August 1991.
As co-chair together with R.-D. Treede he also chaired the working group on the classification of chronic pain in ICD-11. The classification proposal of this working group for chronic pain was officially included in the draft for ICD-11 by the World Health Assembly 2019, which will become the worldwide basis for the classification of physical and mental diseases. Since 2004, he has increasingly expanded his research focus to the topic of placebo and nocebo mechanisms in medical interventions and since 2010 has headed a corresponding transregional DFG research group (DFG 1328).
General Purpose Standing Committee No. 5, Parliament of New South Wales (16 December 2009). "Final Report, Rural Wind Farms". A 2014 paper suggests that the 'Wind Turbine Syndrome' is mainly caused by the nocebo effect and other psychological mechanisms. Australian science magazine Cosmos states that although the symptoms are real for those who suffer from the condition, doctors need to first eliminate known causes (such as pre-existing cancers or thyroid disease) before reaching definitive conclusions with the caveat that new technologies often bring new, previously unknown health risks.
In the narrowest sense, a nocebo response occurs when a drug-trial subject's symptoms are worsened by the administration of an inert, sham, or dummy (simulator) treatment, called a placebo. According to current pharmacological knowledge and the current understanding of cause and effect, a placebo contains no chemical (or any other agent) that could possibly cause any of the observed worsening in the subject's symptoms. Thus, any change for the worse must be due to some subjective factor. Adverse expectations can also cause the analgesic effects of anesthetic medications to disappear.
A number of researchers have pointed out that the harm caused by communicating with patients about potential treatment adverse events raises an ethical issue. Informing a patient about what harms a treatment is likely to cause is required to respect autonomy. Yet the way in which potential harms are communicated could cause additional harm, which may violate the ethical principle of non-maleficence. It may be possible that nocebo effects can be reduced while respecting autonomy using different models of informed consent, including the use of a framing effect.
There are also concerns that some people may develop electrosensitivity from excessive exposure to electromagnetic fields, although these symptoms may be primarily psychological in origin due to the nocebo effect. Using a cell phone before bed can cause insomnia, according to a study by scientists from the Karolinska Institute and Uppsala University in Sweden and from Wayne State University in Michigan. The studyArnetz, Bengt B.; Hillert, Lena; Åkerstedt, Torbjörn; Lowden, Arne; Kuster, Niels; Ebert, Sven; Boutry, Clementine; Moffat, Scott D.; Berg, Mats; Wiholm, Clairy. Effects from 884 MHz mobile phone radiofrequency on brain electrophysiology, sleep, cognition, and well-being, Referierte Publikationen, Chicago, 2008.
He was also President of the German Society of Behavioural Medicine for several years (2001-2005). He was also nominated as a member of the expert commission of the American Psychiatric Association (APA) and World Health Organization (WHO) "Somatic Presentations of Mental Disorders" for the preparation of DSM-5 (Beijing, 2006). In addition, he is spokesperson of the DFG Research Group on Placebo and Nocebo Mechanisms (2010-2019), member of the DFG Review Board (2012-2020), and of the DFG Commission "Clinical Trials". He co-chairs the ICD-11 Working Group on "Classification of Chronic Pain" of the WHO (since 2013).
In scientific research and psychotherapy, the subject-expectancy effect, is a form of reactivity that occurs when a research subject expects a given result and therefore unconsciously affects the outcome, or reports the expected result. Because this effect can significantly bias the results of experiments (especially on human subjects), double-blind methodology is used to eliminate the effect. Like the observer-expectancy effect, it is often a cause of "odd" results in many experiments. The subject-expectancy effect is most commonly found in medicine, where it can result in the subject experiencing the placebo effect or nocebo effect, depending on how the influence pans out.
Due to his exceptional fighting skills, he is seen by Mr. Ral as "the second coming of Reiji". During Gunpla battles, Sekai undergoes with his Gunpla, which makes it an extension of his martial arts skills. Consequently, this assimilation has the nocebo effect of Sekai sustaining physical injuries when his Gunpla is damaged. ; : :Main Gunpla: LGZ-91 Lightning Gundam; LGZ-91Fb Lightning Gundam Full Burnern; MSZ-006LGT Lightning Zeta Gundam; LGZ-91St Lightning Gundam Strider; PF-73-3BL Gundam Lightning Black Warrior :Other Gunpla: GW-9800 Gundam Airmaster; PF-78-3A Gundam Amazing Red Warrior :A second-year student at Seiho Academy and China Kousaka's younger brother.
Research has attempted to discern, by double-blind placebo-controlled trials, between a "fad component" to the recent popularity of the gluten-free diet and an actual sensitivity to gluten or other components of wheat. In a 2013 double-blind, placebo-controlled challenge (DBPC) by Biesiekierski et al. in a few people with irritable bowel syndrome, the authors found no difference between gluten or placebo groups and the concept of NCGS as a syndrome was questioned. Nevertheless, this study had design errors and an incorrect selection of participants, and probably the reintroduction of both gluten and whey protein had a nocebo effect similar in all people, and this could have masked the true effect of gluten/wheat reintroduction.
Claiming critical acclaim by heavy touring and winning several awards in Finland, and making their debut in Germany by touring with Apocalyptica in the autumn of 2007, they proceeded to release their third album Raja in February, 2008, which went straight to No. 1 on the Finnish album chart in the first week. 10 February 2010, Stam1na released their fourth album titled Viimeinen Atlantis, which translates as "The Last Atlantis", which also went straight to first place on the Finnish album chart, topping among others HIM's new release, and was certified gold by ÄKT in its first week of sales. In 2012 Stam1na released their fifth album entitled Nocebo, produced by Joe Barresi.
Methods of diagnosing sleepiness objectively, such as the Multiple Sleep Latency Test do not confirm the symptom"true" sleepiness is not observed despite the complaint. (It may be speculated that such reports of daytime sleepiness may be a result of the nocebo response —the reverse of the placebo effect—due to patient expectations of adverse effects from their subjective perception of poor sleep.) Finally, on the opposite end of the spectrum, other patients may report feeling that they have slept much longer than is observed. It has been proposed that this experience be subclassified under sleep state misperception as "positive sleep state misperception", "reverse sleep state misperception", and "negative sleep state misperception".
According to an article by Hannah Bradby in 2017, there was a risk of the "nocebo effect", the "evil twin" of the placebo effect, where a doctor, through a supposedly neutral medical intervention, brings about unwanted side effects. Well-meaning doctors reinforce the necessity for refugee children's extreme suffering in to persuade the Migration Board to grant residency permits which leads to a self-fulfilling prophecy where the parents decide that only granted residency will make the child healthy again. The idea was criticized as it prevented a proper medical investigation of the child's condition. Bradby also stated that within days, after the child is separated from the parents, regardless of the previous condition of the child, the child becomes healthy eating and drinking like normal.
There are also reasons why a placebo treatment group may outperform a "no-treatment" group in a test which are not related to a patient's experience. These include patients reporting more favourable results than they really felt due to politeness or "experimental subordination", observer bias, and misleading wording of questions. In their 2010 systematic review of studies into placebos, Asbjørn Hróbjartsson and Peter C. Gøtzsche write that "even if there were no true effect of placebo, one would expect to record differences between placebo and no-treatment groups due to bias associated with lack of blinding." Alternative therapies may also be credited for perceived improvement through decreased use or effect of medical treatment, and therefore either decreased side effects or nocebo effects towards standard treatment.
A third problem is that the prescriber does not know whether the relevant subjects consider the effects that they experience to be desirable or undesirable until some time after the drugs have been administered. A fourth problem is that the same phenomena are being generated in all the subjects, and these are being generated by the same drug, which is acting in all of the subjects through the same mechanism. Yet because the phenomena in question have been subjectively considered to be desirable to one group but not the other, the phenomena are now being labelled in two mutually exclusive ways (i.e., placebo and nocebo); and this is giving the false impression that the drug in question has produced two different phenomena.
In a 2013 double-blind, placebo-controlled challenge (DBPC) by Biesiekierski et al. in a few people with irritable bowel syndrome, the authors found no difference between gluten or placebo groups and the concept of non-celiac gluten sensitivity as a syndrome was questioned. Nevertheless, this study had design errors and an incorrect selection of participants, and probably the reintroduction of both gluten and whey protein had a nocebo effect similar in all people, and this could have masked the true effect of gluten/wheat reintroduction. In a 2015 double-blind placebo cross-over trial, small amounts of purified wheat gluten triggered gastrointestinal symptoms (such as abdominal bloating and pain) and extra-intestinal manifestations (such as foggy mind, depression and aphthous stomatitis) in self-reported non- celiac gluten sensitivity.
An example of a scenario involving these various effects is as follows: A woman goes to her doctor with a problem. The doctor diagnoses with certainty, and then clearly explains the diagnosis and the expected route towards recovery. If he does this convincingly, calming her, removing fear and instilling hope, she will likely, through the positive expectancy, experience the placebo effect, aiding in her recovery. On the other hand, if her doctor had had little time for her, was uncertain about the diagnosis, and had given her a prescription, combined with a message along the lines of, "this may help sometimes", and added a message about possible horrible side effects (combined, say, with the patient having talked to a neighbor who also speaks along the same lines about the horrible side effects), then the chance of negative subject-expectancy, or nocebo, becomes quite large.
The majority of provocation trials to date have found that such claimants are unable to distinguish between exposure and non-exposure to electromagnetic fields. A systematic review of medical research in 2011 found no convincing scientific evidence for symptoms being caused by electromagnetic fields. Since then, several double-blind experiments have shown that people who report electromagnetic hypersensitivity are unable to detect the presence of electromagnetic fields and are as likely to report ill health following a sham exposure as they are following exposure to genuine electromagnetic fields, suggesting the cause in these cases to be the nocebo effect. the WHO recommended that people presenting with claims of EHS be evaluated to determine if they have a medical condition that may be causing the symptoms the person is attributing to EHS, that they have a psychological evaluation, and that the person's environment be evaluated for issues like air or noise pollution that may be causing problems.

No results under this filter, show 117 sentences.

Copyright © 2024 RandomSentenceGen.com All rights reserved.